Lung cancer: diagnosis,staging and treatment |
| |
Authors: | Elaine TehElizabeth Belcher |
| |
Affiliation: | Elaine Teh BMedSci BMBS MRCS MD(Res) is a Thoracic Surgical Fellow at Oxford University Hospitals NHS Trust, John Radcliffe Hospital, Oxford, UK. Conflicts of interest: none declared; Elizabeth Belcher MRCP FRCS PhD is a Consultant Thoracic Surgeon at Oxford University Hospitals NHS Trust, Oxford, UK. Conflicts of interest: none declared |
| |
Abstract: | Lung cancer is the most common malignancy worldwide and carries a high mortality rate. The risk of developing lung cancer is strongly associated with smoking. The predominant subtypes of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC forms the majority of cases while SCLC makes up a smaller proportion. Patients with symptoms and signs suggestive of lung cancer are managed by a multi-disciplinary team approach in order to diagnose and stage the disease. The type and stage of lung cancer guides further management. Early stage lung cancer should be treated aggressively; with the most appropriate modality which may include surgery, chemotherapy and radiotherapy, or a combination of these various modalities. |
| |
Keywords: | Lung cancer non-small cell lung cancer surgery targeted therapy |
本文献已被 ScienceDirect 等数据库收录! |